New reports suggest that the treatment of HIV/AIDS has seen a remarkable development. According to reports, HIV/AIDS patient may soon have access to a treatment regiment that better manage the condition compared to those already available to individuals diagnosed with the condition. This progress was made possible by the formulation of a new anti-retroviral drug therapy coupled with some amazing tools that have been designed to check whether or not the condition of a particular patient is resisting the drug.
The research and discovery were made by a medical team at the University of Arizona College of Medicine. The study titled HIV Infection-Associated Frailty: The Solution for Now, is Antiretroviral Drugs was published on February 25, 2019, in the Journal of the International Association of AIDS Care Providers. This is amazing news for HIV/AIDS patients as this will significantly provide a better way to manage the condition efficiently. According to a report, the new treatment regimen will make the HIV/AIDS virus almost undetectable in individuals that adhere strictly to the therapy.
“We have shown that years of antiretroviral therapy can return patients to a non-frail state. In addition, prolonged antiretroviral therapy restores cellular function and numbers of cells adversely affected by HIV,” lead author of the study, Stephen A. Klotz, MD, professor in the Division of Infectious Diseases in the UA Department of Medicine said. He added that “Recently we demonstrated a marked improvement in aging markers in HIV patients on long-term anti-retroviral drug therapy.”
Klots stated that individuals diagnosed with HIV/AIDS often experience significant frailty in the past, which may lead patients to appear up to 15 years older than their actual age. This effect may also extend to their function and activities. It is reported that the team of researchers also adopted a major innovation in the treatment of the condition known as “Frailty Meter” developed by the then a professor in the UA Department of Surgery and director of the Consortium on Advanced Motion Performance – Bijan Najafi, Ph.D., MSc.
The device will allow medical practitioners to check the frailty of individuals diagnosed with HIV/AIDS in a few seconds. This is done through a Bluetooth compatible motion sensor that is attached to the wrist of the patient